Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model.

Wasa J, Sugiura H, Kozawa E, Kohyama K, Yamada K, Taguchi O.

Anticancer Res. 2011 Jan;31(1):123-7.

PMID:
21273589
[PubMed - indexed for MEDLINE]
2.

Decorin suppresses lung metastases of murine osteosarcoma.

Shintani K, Matsumine A, Kusuzaki K, Morikawa J, Matsubara T, Wakabayashi T, Araki K, Satonaka H, Wakabayashi H, Iino T, Uchida A.

Oncol Rep. 2008 Jun;19(6):1533-9.

PMID:
18497961
[PubMed - indexed for MEDLINE]
3.

Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer.

Kosugi M, Miyajima A, Kikuchi E, Horiguchi Y, Murai M.

Clin Cancer Res. 2006 May 1;12(9):2888-93.

PMID:
16675585
[PubMed - indexed for MEDLINE]
Free Article
4.

Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer.

Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M.

Hum Cell. 2007 Feb;20(1):1-9.

PMID:
17506771
[PubMed - indexed for MEDLINE]
5.

Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma.

Mori S, Ueda T, Kuratsu S, Hosono N, Izawa K, Uchida A.

Int J Cancer. 1995 Mar 29;61(1):148-52.

PMID:
7535752
[PubMed - indexed for MEDLINE]
6.

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.

Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F.

Clin Cancer Res. 2005 Apr 1;11(7):2686-94.

PMID:
15814650
[PubMed - indexed for MEDLINE]
Free Article
7.

Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy.

Tanaka T, Yui Y, Naka N, Wakamatsu T, Yoshioka K, Araki N, Yoshikawa H, Itoh K.

Clin Exp Metastasis. 2013 Apr;30(4):369-79. doi: 10.1007/s10585-012-9543-8. Epub 2012 Oct 18.

PMID:
23076771
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Antimetastatic activity of honokiol in osteosarcoma.

Steinmann P, Walters DK, Arlt MJ, Banke IJ, Ziegler U, Langsam B, Arbiser J, Muff R, Born W, Fuchs B.

Cancer. 2012 Apr 15;118(8):2117-27. doi: 10.1002/cncr.26434. Epub 2011 Sep 20.

PMID:
21935912
[PubMed - indexed for MEDLINE]
Free Article
9.

Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis.

Miyajima A, Kosaka T, Asano T, Asano T, Seta K, Kawai T, Hayakawa M.

Cancer Res. 2002 Aug 1;62(15):4176-9.

PMID:
12154013
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.

Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA.

J Gastrointest Surg. 2008 Jan;12(1):57-66. Epub 2007 Nov 17.

PMID:
18026817
[PubMed - indexed for MEDLINE]
12.

Overexpression of factor inhibiting HIF-1 enhances vessel maturation and tumor growth via platelet-derived growth factor-C.

Kuzmanov A, Wielockx B, Rezaei M, Kettelhake A, Breier G.

Int J Cancer. 2012 Sep 1;131(5):E603-13. doi: 10.1002/ijc.27360. Epub 2012 Jan 3.

PMID:
22095574
[PubMed - indexed for MEDLINE]
13.

Postoperative progression of pulmonary metastasis in osteosarcoma.

Tsunemi T, Nagoya S, Kaya M, Kawaguchi S, Wada T, Yamashita T, Ishii S.

Clin Orthop Relat Res. 2003 Feb;(407):159-66.

PMID:
12567143
[PubMed - indexed for MEDLINE]
14.

Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model.

Hara K, Kusuzaki K, Takeshita H, Kuzuhara A, Tsuji Y, Ashihara T, Hirasawa Y.

Anticancer Res. 2001 Jan-Feb;21(1A):321-4.

PMID:
11299756
[PubMed - indexed for MEDLINE]
15.

Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts.

Huang W, Wu YL, Zhong J, Jiang FX, Tian XL, Yu LF.

Dig Dis Sci. 2008 May;53(5):1206-10. Epub 2007 Oct 13.

PMID:
17934850
[PubMed - indexed for MEDLINE]
16.

Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression.

Ohnuma Y, Toda M, Fujita M, Hosono K, Suzuki T, Ogawa Y, Amano H, Kitasato H, Hayakawa K, Majima M.

Biomed Pharmacother. 2009 Feb;63(2):136-45. doi: 10.1016/j.biopha.2007.11.005. Epub 2007 Dec 26.

PMID:
18691848
[PubMed - indexed for MEDLINE]
17.

Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer.

Kosaka T, Miyajima A, Takayama E, Kikuchi E, Nakashima J, Ohigashi T, Asano T, Sakamoto M, Okita H, Murai M, Hayakawa M.

Prostate. 2007 Jan 1;67(1):41-9.

PMID:
17044086
[PubMed - indexed for MEDLINE]
18.

Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis.

Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T, Kitamura H, Umemura S.

Lab Invest. 2007 Feb;87(2):189-98. Epub 2006 Dec 18.

PMID:
17318197
[PubMed - indexed for MEDLINE]
Free Article
19.

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.

Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M.

Biochem Biophys Res Commun. 2002 Jun 7;294(2):441-7.

PMID:
12051731
[PubMed - indexed for MEDLINE]
20.

Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.

Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA.

Mol Cancer Ther. 2009 Jun;8(6):1676-83. doi: 10.1158/1535-7163.MCT-09-0161. Epub 2009 Jun 9.

PMID:
19509262
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk